title: CD30 expression in cutaneous B-cell and post-transplant peripheral T-cell lymphoma: report of 2 cases.
abstract: CD30 expression is the hallmark of the cutaneous CD30+ lymphoproliferative disorders, lymphomatoid papulosis and anaplastic large cell lymphoma. We report CD30 expression in cutaneous follicle center cell lymphoma and in cutaneous post-transplant peripheral T-cell lymphoma. Histopathologists should be aware of CD30 expression in cutaneous lymphomas outside the realm of so-called CD30+ lymphoproliferative disorders to avoid diagnostic errors and improper medical treatment.
authors.forename: Hana
authors.initials: H
authors.lastname: Albrecht
authors.forename: Janet M
authors.initials: JM
authors.lastname: Woodroof
authors.forename: Ruben
authors.initials: R
authors.lastname: Reyes
authors.forename: Benjamin C
authors.initials: BC
authors.lastname: Powers
authors.affiliation: University of Kansas Medical Center.
authors.forename: Garth R
authors.initials: GR
authors.lastname: Fraga
mesh_terms: D000368:Aged; D001402:B-Lymphocytes / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D001706:Biopsy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D017730:Ki-1 Antigen / Q000096:biosynthesis* / Q000276:immunology; D016411:Lymphoma, T-Cell, Peripheral / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D008875:Middle Aged; D011379:Prognosis; D012867:Skin / Q000276:immunology / Q000473:pathology*; D012878:Skin Neoplasms / Q000276:immunology* / Q000378:metabolism / Q000473:pathology
chemical_list: D017730:Ki-1 Antigen